Evidence map›Paper›PMID 25522171›Full record

ArticleInternational journal of molecular sciences2014

PRRT2 mutations are related to febrile seizures in epileptic patients.

Zheng-Wen He, Jian Qu, Ying Zhang, Chen-Xue Mao, Zhi-Bin Wang, Xiao-Yuan Mao, Zhi-Yong Deng, Bo-Ting Zhou, Ji-Ye Yin, Hong-Yu Long and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. A comparative cohort study of epilepsy in children in Greenland and Denmark.International journal of circumpolar health · 2025
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Toward Precision Medicine: How Far Is the Goal?International journal of molecular sciences · 2016
    Article
  8. PRRT2 Mutant Leads to Dysfunction of Glutamate Signaling.International journal of molecular sciences · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Zheng-Wen HeDepartment of Neurosurgery, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410014, China. hezhengw@gmail.com.
Jian QuDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. seemore126@gmail.com.
Ying ZhangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. yz_fly@csu.edu.cn.
Chen-Xue MaoDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. sharemix@csu.edu.cn.
Zhi-Bin WangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. wangzhibinup@gmail.com.
Xiao-Yuan MaoDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. xiaoyuanm@csu.edu.cn.
Zhi-Yong DengDepartment of Neurosurgery, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410014, China. dzyong111@gmail.com.
Bo-Ting ZhouInstitute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, China. botingzhou0918@gmail.com.
Ji-Ye YinDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. yinjiye@csu.edu.cn.
Hong-Yu LongDepartments of Pharmacy and Neurology, Xiangya Hospital, Central South University, Changsha 410008, China. longhongyu@csu.edu.cn.
Bo XiaoDepartments of Pharmacy and Neurology, Xiangya Hospital, Central South University, Changsha 410008, China. boxiaoxiao123@gmail.com.
Yu ZhangDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. yz_fly@csu.edu.cn.
Hong-Hao ZhouDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. honghaozhou2012@gmail.com.
Zhao-Qian LiuDepartment of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China. zqliu@mail.csu.edu.cn.
Central South University · CNXiangya Hospital Central South University · CNHunan Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies reported that the proline-rich transmembrane protein 2 (PRRT2) gene was identified to be related to paroxysmal kinesigenic dyskinesia (PKD), infantile convulsions with PKD, PKD with migraine and benign familial infantile epilepsy (BFIE). The present study explores whether the PRRT2 mutation is a potential cause of febrile seizures, including febrile seizures plus (FS+), generalized epilepsy with febrile seizures plus (GEFS+) and Dravet syndrome (DS); thus, it may provide a new drug target for personalized medicine for febrile seizure patients. We screened PRRT2 exons in a cohort of 136 epileptic patients with febrile seizures, including FS+, GEFS+ and DS. PRRT2 genetic mutations were identified in 25 out of 136 (18.4%) febrile seizures in epileptic patients. Five loss-of-function and coding missense mutations were identified: c.649delC (p.R217Efs*12), c.649_650insC (p.R217Pfs*8), c.412C>G (p.Pro138Ala), c.439G>C (p.Asp147His) and c.623C>A (p.Ser208Tyr). PRRT2 variants were probably involved in the etiology of febrile seizures in epileptic patients.

Indexed as

Genetic Association StudiesMutationAdolescentAdultAge of OnsetChildChild, PreschoolDNA Mutational AnalysisFemaleGenetic Predisposition to DiseaseHumansMaleMembrane ProteinsNerve Tissue ProteinsSeizures, FebrileYoung AdultMembrane ProteinsNerve Tissue ProteinsPRRT2 protein, human

Identifiers

PMID25522171
PMCPMC4284774
OpenAlexW2058416249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.